XML 123 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Unaudited Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Common Stock
Additional paid-in capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2020   0 90,121      
Beginning balance at Dec. 31, 2020 $ 191,563 $ 0 $ 90 $ 756,543 $ (565,073) $ 3
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under employee stock compensation plan (in shares)     49      
Issuance of common stock under employee stock compensation plans 129     129    
Share-based compensation 2,292     2,292    
Net loss (26,795)       (26,795)  
Unrealized loss on available for sale securities, net of tax (1)         (1)
Balance at end of period (in shares) at Mar. 31, 2021   0 90,170      
Ending balance at Mar. 31, 2021 167,188 $ 0 $ 90 758,964 (591,868) 2
Balance at beginning of period (in shares) at Dec. 31, 2020   0 90,121      
Beginning balance at Dec. 31, 2020 191,563 $ 0 $ 90 756,543 (565,073) 3
Increase (Decrease) in Stockholders' Equity            
Net loss (56,938)          
Balance at end of period (in shares) at Jun. 30, 2021   0 90,387      
Ending balance at Jun. 30, 2021 139,573 $ 0 $ 90 761,491 (622,011) 3
Balance at beginning of period (in shares) at Mar. 31, 2021   0 90,170      
Beginning balance at Mar. 31, 2021 167,188 $ 0 $ 90 758,964 (591,868) 2
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under employee stock compensation plan (in shares)     217      
Issuance of common stock under employee stock compensation plans 448     448    
Share-based compensation 2,079     2,079    
Net loss (30,143)       (30,143)  
Unrealized loss on available for sale securities, net of tax 1         1
Balance at end of period (in shares) at Jun. 30, 2021   0 90,387      
Ending balance at Jun. 30, 2021 139,573 $ 0 $ 90 761,491 (622,011) 3
Balance at beginning of period (in shares) at Dec. 31, 2021   0 115,277      
Beginning balance at Dec. 31, 2021 360,528 $ 0 $ 115 1,040,098 (679,595) (90)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under employee stock compensation plan (in shares)     697      
Issuance of common stock under employee stock compensation plans 2,080   $ 1 2,079    
Share-based compensation 5,386     5,386    
Net loss (34,536)       (34,536)  
Unrealized loss on available for sale securities, net of tax (304)         (304)
Balance at end of period (in shares) at Mar. 31, 2022   0 115,974      
Ending balance at Mar. 31, 2022 333,154 $ 0 $ 116 1,047,563 (714,131) (394)
Balance at beginning of period (in shares) at Dec. 31, 2021   0 115,277      
Beginning balance at Dec. 31, 2021 360,528 $ 0 $ 115 1,040,098 (679,595) (90)
Increase (Decrease) in Stockholders' Equity            
Net loss (83,799)          
Balance at end of period (in shares) at Jun. 30, 2022   0 116,874      
Ending balance at Jun. 30, 2022 292,946 $ 0 $ 117 1,056,751 (763,394) (528)
Balance at beginning of period (in shares) at Mar. 31, 2022   0 115,974      
Beginning balance at Mar. 31, 2022 333,154 $ 0 $ 116 1,047,563 (714,131) (394)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under employee stock compensation plan (in shares)     900      
Issuance of common stock under employee stock compensation plans 2,801   $ 1 2,800    
Share-based compensation 6,388     6,388    
Net loss (49,263)       (49,263)  
Unrealized loss on available for sale securities, net of tax (134)         (134)
Balance at end of period (in shares) at Jun. 30, 2022   0 116,874      
Ending balance at Jun. 30, 2022 $ 292,946 $ 0 $ 117 $ 1,056,751 $ (763,394) $ (528)